Kathryn Berndtson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
- develop regulatory and intellectual property frameworks for commercialization of biotechnology
- survey and build capacity based on proven models through education
- improve the academic-industry interface and the role of small
- enhance funding and affordability of biotechnology
- and needs assessments finance:
Kathryn Berndtson has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah S. Daar
McLaughlin-Rotman Centre for Global Health, at the University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada
2 shared publications - Deepa L Persad
McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, Canada
2 shared publications - Peter A. Singer
University of Toronto Joint Centre for Bioethics, Toronto, Canada
2 shared publications Abdallah S Daar
1 shared publicationAnant Bhan
1 shared publicationC. Shawn Tracy
1 shared publication
Latest Publications
- Open Access
- 20 May 2008
- Published by Springer Nature in BMC Public Health
- Vol. 8 (1) , 168
Public engagement on global health challenges
Experience with public engagement activities regarding the risks and benefits of science and technology (S&T) is growing, especially in the industrialized world. However, public engagement in the developing world regarding S&T risks and benefits to explore health issues has not been widely explored.
- 20 May 2008
- Published by Springer Nature in BMC Public Health
- Vol. 8 (1) , 168
Open AccessPublic engagement on global health challenges
Experience with public engagement activities regarding the risks and benefits of science and technology (S&T) is growing, especially in the industrialized world. However, public engagement in the developing world regarding S&T risks and benefits to explore health issues has not been widely explored.
- Open Access
- 3 December 2007
- Published by Springer Nature in BMC Public Health
- Vol. 7 (1) , 346
How can developing countries harness biotechnology to improve health?
The benefits of genomics and biotechnology are concentrated primarily in the industrialized world, while their potential to combat neglected diseases in the developing world has been largely untapped. Without building developing world biotechnology capacity to address local health needs, this disparity will only intensify. To assess the potential of genomics to address health needs in the developing world, the McLaughlin-Rotman Centre for Global Health, along with local partners, organized five courses on Genomics and Public Health Policy in the developing world. The overall objective of the courses was to collectively explore how to best harness genomics to improve health in each region. This article presents and analyzes the recommendations from all five courses.
- 3 December 2007
- Published by Springer Nature in BMC Public Health
- Vol. 7 (1) , 346
Open AccessHow can developing countries harness biotechnology to improve health?
The benefits of genomics and biotechnology are concentrated primarily in the industrialized world, while their potential to combat neglected diseases in the developing world has been largely untapped. Without building developing world biotechnology capacity to address local health needs, this disparity will only intensify. To assess the potential of genomics to address health needs in the developing world, the McLaughlin-Rotman Centre for Global Health, along with local partners, organized five courses on Genomics and Public Health Policy in the developing world. The overall objective of the courses was to collectively explore how to best harness genomics to improve health in each region. This article presents and analyzes the recommendations from all five courses.
- Open Access
- 11 September 2007
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 4 (9) , e268
Grand Challenges in Global Health: Ethical, Social, and Cultural Issues Based on Key Informant Perspectives
The authors interviewed key informants from the developing world and the Grand Challenges investigators to explore their ethical, social, and cultural concerns about the program.
- 11 September 2007
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 4 (9) , e268
Open AccessGrand Challenges in Global Health: Ethical, Social, and Cultural Issues Based on Key Informant Perspectives
The authors interviewed key informants from the developing world and the Grand Challenges investigators to explore their ethical, social, and cultural concerns about the program.